Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: Management of advanced phases of CML

  Mhairi Copland

Expert:

Professor Mhairi Copland
Professor of Translational Haematology
University of Glasgow
(UK)

iCMLf Conversation: CML Highlights of ASH 2022 - Clinical overview

Michael Mauro

Expert:

Professor Michael Mauro
Leader of the Myeloproliferative Neoplams Program at the Memorial Sloan Kettering Cancer Centre / Professor of Clinical Medicine at the Weill Cornell Medical College, New York (USA)

iCMLf Conversation: CML Highlights of ASH 2022 - Biological overview

Ravi Bhatia

Expert:

Professor Ravi Bhatia
Director of the Stem Cell Program at the University of Alabama in Birmingham (USA)

iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Biological overview

Daniela Krause

Expert:

Professor Daniela Krause
Research Group Leader at Georg Speyer Haus / Goethe University, Frankfurt (Germany)

iCMLf Conversation: Highlights of the 24th John Goldman E-Conference - Clinical overview incl. Q&A Session

Jorge Cortes 2013

Expert:

Professor Jorge Cortes
Georgia Cancer Centre, Augusta (USA)